AR-42: A Pan-HDAC Inhibitor with Antitumor and Antiangiogenic Activities in Esophageal Squamous Cell Carcinoma

Zhu, YX; Yuan, T; Zhang, Y; Shi, JY; Bai, L; Duan, XM; Tong, RS; Zhong, L

Tong, RS; Zhong, L (reprint author), Univ Elect Sci & Technol China, Sichuan Prov Peoples Hosp, Dept Pharm, Personalized Drug Therapy Key Lab Sichuan Prov, 32 West Second Sect First Ring Rd, Chengdu 610072, Sichuan, Peoples R China.

DRUG DESIGN DEVELOPMENT AND THERAPY, 2019; 13 (): 4321